Cloned and transfected P2Y4 receptors: characterization of a suramin and PPADS‐insensitive response to UTP
Open Access
- 1 December 1996
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 119 (7) , 1301-1303
- https://doi.org/10.1111/j.1476-5381.1996.tb16038.x
Abstract
The P2Y family of receptors are G protein‐coupled receptors for ATP, ADP, UTP and UDP. Recently several members of this family have been cloned, including the P2Y4, which is activated by UTP but not by ATP. In the present report, using receptors stably transfected into 1321N1 cells, we show that suramin acts as an antagonist at cloned P2Y1 and (less potently) P2Y2 receptors, but not at the cloned P2Y4 receptor. Furthermore, PPADS (pyridoxal‐phosphate‐6‐azophenyl‐2′,4′‐disulphonic acid), a potent antagonist at the P2Y1 receptor, is a relatively inneffective antagonist at the cloned P2Y4 receptor. This work moves us closer to the goal of classifying the native P2Y receptors on the basis of agonist and antagonist profiles.Keywords
This publication has 10 references indexed in Scilit:
- PPADS and suramin as antagonists at cloned P2Y‐ and P2U‐purinoceptorsBritish Journal of Pharmacology, 1996
- Discrimination by PPADS between endothelial P2Y- and P2U- purinoceptors in the rat isolated mesenteric arterial bedBritish Journal of Pharmacology, 1996
- Cloning, Functional Expression and Tissue Distribution of the Human P2Y6ReceptorBiochemical and Biophysical Research Communications, 1996
- Identification of 6H1 as a P2YPurinoceptor: P2Y5Biochemical and Biophysical Research Communications, 1996
- Cloning, Expression, and Chromosomal Localization of the Human Uridine Nucleotide Receptor GenePublished by Elsevier ,1995
- Molecular Cloning and Functional Analysis of a Novel P2 Nucleotide ReceptorJournal of Biological Chemistry, 1995
- PPADS: an antagonist at endothelial P2Y‐purinoceptors but not P2U‐purinoceptorsBritish Journal of Pharmacology, 1995
- Expression of a cloned P2Y purinergic receptor that couples to phospholipase C.1994
- Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy.Proceedings of the National Academy of Sciences, 1994